Retinal Ganglion Cell Function and Perfusion following Intraocular Pressure Reduction with Preservative-Free Latanoprost in Patients with Glaucoma and Ocular Hypertension

被引:0
|
作者
Daka, Qendrese [1 ,2 ]
Sustar Habjan, Maja [2 ]
Meglic, Andrej [2 ]
Perovsek, Darko [2 ]
Atanasovska Velkovska, Makedonka [2 ]
Cvenkel, Barbara [2 ,3 ]
机构
[1] Univ Prishtina, Med Fac, Dept Pathophysiol, Prishtina 10000, Kosovo
[2] Univ Med Ctr Ljubljana, Dept Ophthalmol, Ljubljana 1000, Slovenia
[3] Univ Ljubljana, Fac Med, Ljubljana 1000, Slovenia
关键词
retinal ganglion cell; preservative-free latanoprost; electroretinogram; optical coherence tomography; optical coherence tomography angiography; PHOTOPIC NEGATIVE RESPONSE; OPEN-ANGLE GLAUCOMA; OPTIC-NERVE HEAD; PATTERN ELECTRORETINOGRAM; VESSEL DENSITY; MACULAR PERFUSION; PROGRESSIVE LOSS; BLOOD-FLOW; PERIPAPILLARY; REPEATABILITY;
D O I
10.3390/jcm13051226
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
(1) Background: Given the global prevalence of glaucoma and the crucial role of intraocular pressure (IOP) reduction in the management of the disease, understanding the immediate effects on retinal structure and function is essential. (2) Methods: This study aimed to assess the effects of preservative-free latanoprost on morphological and functional parameters in treatment-naive patients with ocular hypertension and open-angle glaucoma. (3) Results: This study showed a significant reduction in IOP by an average of 30.6% after treatment with preservative-free latanoprost. Despite the significant reduction in IOP, no statistically significant changes were observed in the electroretinogram (ERG) nor the optical coherence tomography/angiography (OCT/OCTA) parameters compared to baseline. An exploration of the correlation between IOP changes and various parameters revealed a significant association solely with the macular IPL/INL plexus vessel density (VD) measured with OCTA. (4) Conclusions: This finding suggests a possible association between IOP reduction and changes in the macular microcirculation and provides valuable insights into the differential effects of latanoprost. Acknowledging the study limitations, this study emphasizes the need for larger, longer-term investigations to comprehensively assess the sustained effects of preservative-free latanoprost on both IOP and retinal parameters. In addition, exploring systemic factors and conducting subgroup analyses could improve personalized approaches to glaucoma treatment.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Efficacy and patient tolerability of preservative-free latanoprost compared with preservative prostaglandin analogs in patients with ocular hypertension or glaucoma
    El Ameen, A.
    Vandermeer, G.
    Pisella, P. J.
    [J]. ACTA OPHTHALMOLOGICA, 2016, 94
  • [2] Efficacy and safety of preservative-free latanoprost eyedrops, compared with BAK-preserved latanoprost in patients with ocular hypertension or glaucoma
    Rouland, Jean-Francois
    Traverso, Carlo Enrico
    Stalmans, Ingeborg
    El Fekih, Lamia
    Delval, Laurent
    Renault, Didier
    Baudouin, Christophe
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2013, 97 (02) : 196 - 200
  • [3] The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
    Misiuk-Hojlo, Marta
    Pomorska, Maria
    Mulak, Malgorzata
    Rekas, Marek
    Wierzbowska, Joanna
    Prost, Marek
    Wasyluk, Jaromir
    Lubinski, Wojciech
    Podboraczynska-Jodko, Karolina
    Romaniuk, Wanda
    Kinasz, Renata
    Ortyl-Markiewicz, Renata
    Mocko, Lucyna
    Zaleska-Zmijewska, Anna
    Rokicki, Dariusz
    Baudouin, Christophe
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2019, 29 (02) : 210 - 215
  • [4] Preservative-Free Latanoprost Eye Drops in Patients with Primary Open-Angle Glaucoma/Ocular Hypertension
    Mark Sanford
    [J]. Clinical Drug Investigation, 2014, 34 : 521 - 528
  • [5] Preservative-Free Latanoprost Eye Drops in Patients with Primary Open-Angle Glaucoma/Ocular Hypertension
    Sanford, Mark
    [J]. CLINICAL DRUG INVESTIGATION, 2014, 34 (07) : 521 - 528
  • [6] Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension
    Aptel, Florent
    Choudhry, Reena
    Stalmans, Ingeborg
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (08) : 1457 - 1463
  • [7] Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension
    Carl Erb
    Ines Lanzl
    Seid-Fatima Seidova
    Friedemann Kimmich
    [J]. Advances in Therapy, 2011, 28
  • [8] Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension
    Lanzl, Ines
    Hamacher, Thomas
    Rosbach, Klaus
    Ramez, Mohammed Osman
    Rothe, Robert
    Ruzickova, Eva
    Karhanova, Marta
    Kimmich, Friedemann
    [J]. CLINICAL OPHTHALMOLOGY, 2013, 7 : 901 - 909
  • [9] Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension
    Lanzl, Ines
    Hamacher, Thomas
    Kimmich, Friedemann
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [10] Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension
    Erb, Carl
    Lanzl, Ines
    Seidova, Seid-Fatima
    Kimmich, Friedemann
    [J]. ADVANCES IN THERAPY, 2011, 28 (07) : 575 - 585